245 related articles for article (PubMed ID: 30452972)
1. Silibinin inhibits endometrial carcinoma via blocking pathways of STAT3 activation and SREBP1-mediated lipid accumulation.
Shi Z; Zhou Q; Gao S; Li W; Li X; Liu Z; Jin P; Jiang J
Life Sci; 2019 Jan; 217():70-80. PubMed ID: 30452972
[TBL] [Abstract][Full Text] [Related]
2. Silibinin inhibits aberrant lipid metabolism, proliferation and emergence of androgen-independence in prostate cancer cells via primarily targeting the sterol response element binding protein 1.
Nambiar DK; Deep G; Singh RP; Agarwal C; Agarwal R
Oncotarget; 2014 Oct; 5(20):10017-33. PubMed ID: 25294820
[TBL] [Abstract][Full Text] [Related]
3. Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells.
Agarwal C; Tyagi A; Kaur M; Agarwal R
Carcinogenesis; 2007 Jul; 28(7):1463-70. PubMed ID: 17341659
[TBL] [Abstract][Full Text] [Related]
4. Silibinin inhibits proliferation, induces apoptosis and causes cell cycle arrest in human gastric cancer MGC803 cells via STAT3 pathway inhibition.
Wang YX; Cai H; Jiang G; Zhou TB; Wu H
Asian Pac J Cancer Prev; 2014; 15(16):6791-8. PubMed ID: 25169527
[TBL] [Abstract][Full Text] [Related]
5. Acrp30 inhibits leptin-induced metastasis by downregulating the JAK/STAT3 pathway via AMPK activation in aggressive SPEC-2 endometrial cancer cells.
Wu X; Yan Q; Zhang Z; Du G; Wan X
Oncol Rep; 2012 May; 27(5):1488-96. PubMed ID: 22327423
[TBL] [Abstract][Full Text] [Related]
6. Effect of silibinin on CFLAR-JNK pathway in oleic acid-treated HepG2 cells.
Liu Y; Yu Q; Chen Y
Biomed Pharmacother; 2018 Dec; 108():716-723. PubMed ID: 30248539
[TBL] [Abstract][Full Text] [Related]
7. BF175 inhibits endometrial carcinoma through SREBP-regulated metabolic pathways in vitro.
Wang Q; Hu R; Li W; Tai Y; Gu W; Das BC; Yang F; Ji J; Wang C; Zhou J
Mol Cell Endocrinol; 2021 Mar; 523():111135. PubMed ID: 33359761
[TBL] [Abstract][Full Text] [Related]
8. Functionalized Caprolactone-Polyethylene Glycol Based Thermo-Responsive Hydrogels of Silibinin for the Treatment of Malignant Melanoma.
Makhmalzadeh BS; Molavi O; Vakili MR; Zhang HF; Solimani A; Abyaneh HS; Loebenberg R; Lai R; Lavasanifar A
J Pharm Pharm Sci; 2018; 21(1):143-159. PubMed ID: 29789104
[TBL] [Abstract][Full Text] [Related]
9. Silibinin promotes the apoptosis of gastric cancer BGC823 cells through caspase pathway.
Li R; Yu J; Wang C
J BUON; 2017; 22(5):1148-1153. PubMed ID: 29135096
[TBL] [Abstract][Full Text] [Related]
10. Anti-Tumor Activity and Mechanism of Silibinin Based on Network Pharmacology and Experimental Verification.
Li P; Wang D; Yang X; Liu C; Li X; Zhang X; Liu K; Zhang Y; Zhang M; Wang C; Wang R
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675723
[TBL] [Abstract][Full Text] [Related]
11. Silibinin protects β cells from glucotoxicity through regulation of the Insig-1/SREBP-1c pathway.
Chen K; Zhao L; He H; Wan X; Wang F; Mo Z
Int J Mol Med; 2014 Oct; 34(4):1073-80. PubMed ID: 25109869
[TBL] [Abstract][Full Text] [Related]
12. Silibinin, A Natural Blend In Polytherapy Formulation For Targeting Cd44v6 Expressing Colon Cancer Stem Cells.
Patel S; Waghela B; Shah K; Vaidya F; Mirza S; Patel S; Pathak C; Rawal R
Sci Rep; 2018 Nov; 8(1):16985. PubMed ID: 30451890
[TBL] [Abstract][Full Text] [Related]
13. Combined treatment with sorafenib and silibinin synergistically targets both HCC cells and cancer stem cells by enhanced inhibition of the phosphorylation of STAT3/ERK/AKT.
Mao J; Yang H; Cui T; Pan P; Kabir N; Chen D; Ma J; Chen X; Chen Y; Yang Y
Eur J Pharmacol; 2018 Aug; 832():39-49. PubMed ID: 29782854
[TBL] [Abstract][Full Text] [Related]
14. Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro.
Zhu WQ; Wang J; Guo XF; Liu Z; Dong WG
World J Gastroenterol; 2016 Apr; 22(16):4149-59. PubMed ID: 27122665
[TBL] [Abstract][Full Text] [Related]
15. Silibinin downregulates MMP2 expression via Jak2/STAT3 pathway and inhibits the migration and invasive potential in MDA-MB-231 cells.
Byun HJ; Darvin P; Kang DY; Sp N; Joung YH; Park JH; Kim SJ; Yang YM
Oncol Rep; 2017 Jun; 37(6):3270-3278. PubMed ID: 28440514
[TBL] [Abstract][Full Text] [Related]
16. LncRNA HOXB-AS3 binding to PTBP1 protein regulates lipid metabolism by targeting SREBP1 in endometrioid carcinoma.
Zhou Q; Kong D; Li W; Shi Z; Liu Y; Sun R; Ma X; Qiu C; Liu Z; Hou Y; Jiang J
Life Sci; 2023 May; 320():121512. PubMed ID: 36858312
[TBL] [Abstract][Full Text] [Related]
17. Fatostatin inhibits the development of endometrial carcinoma in endometrial carcinoma cells and a xenograft model by targeting lipid metabolism.
Yao L; Chen S; Li W
Arch Biochem Biophys; 2020 May; 684():108327. PubMed ID: 32142890
[TBL] [Abstract][Full Text] [Related]
18. Salvianolic acids improve liver lipid metabolism in ovariectomized rats via blocking STAT-3/SREBP1 signaling.
Chen J; Yue J; Liu J; Liu Y; Jiao KL; Teng MY; Hu CY; Zhen J; Wu MX; Zhou M; Li Z; Li Y
Chin J Nat Med; 2018 Nov; 16(11):838-845. PubMed ID: 30502765
[TBL] [Abstract][Full Text] [Related]
19. Pien Tze Huang inhibits tumor cell proliferation and promotes apoptosis via suppressing the STAT3 pathway in a colorectal cancer mouse model.
Zhuang Q; Hong F; Shen A; Zheng L; Zeng J; Lin W; Chen Y; Sferra TJ; Hong Z; Peng J
Int J Oncol; 2012 May; 40(5):1569-74. PubMed ID: 22218594
[TBL] [Abstract][Full Text] [Related]
20. The Natural Estrogen Receptor Beta Agonist Silibinin as a Promising Therapeutic Tool in Diffuse Large B-cell Lymphoma.
Ortona E; Locatelli SL; Pagano MT; Ascione B; Careddu G; Dupuis ML; Marconi M; Carlo-Stella C; Malorni W; Matarrese P; Pierdominici M
Anticancer Res; 2022 Feb; 42(2):767-779. PubMed ID: 35093875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]